Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Clk1-in-3 is a + selective and highly potent sexual Clk1 inhibitor with an IC50 of 5 nM and 300 pairs higher affinity than Dyrk1A. CLK1-IN-3 also showed highly effective inhibition of Clk2 and Clk4, with IC50 values of 42 and 108 nM, respectively. CLK1-IN-3 is effective in inducing autophagy in vitro and can be used for prevention and human treatment of acute liver injury (ALI).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 106.00 | |
5 mg | In stock | $ 263.00 | |
10 mg | In stock | $ 428.00 | |
25 mg | In stock | $ 872.00 | |
50 mg | In stock | $ 1,450.00 | |
100 mg | In stock | $ 2,320.00 |
Description | Clk1-in-3 is a + selective and highly potent sexual Clk1 inhibitor with an IC50 of 5 nM and 300 pairs higher affinity than Dyrk1A. CLK1-IN-3 also showed highly effective inhibition of Clk2 and Clk4, with IC50 values of 42 and 108 nM, respectively. CLK1-IN-3 is effective in inducing autophagy in vitro and can be used for prevention and human treatment of acute liver injury (ALI). |
Targets&IC50 | CLK2:42 nM, CLK1:5 nM, DYRK1A:1521 nM, CLK4:108 nM |
In vitro |
CLK1-IN-3 (compound 10ad) demonstrates anti-tumor potential due to its dual inhibitory effects on Clk1 and Clk2[1]. CLK1-IN-3 (10 μM-1000 μM) effectively binds to the Clk1 protein and inhibits its degradation in a dose-dependent manner[1]. CLK1-IN-3 (0-10 μM, 24 h) induces autophagy in Hela, BNLCL.2, and HCT 116 cells[1]. CLK1-IN-3 stimulates the degradation of SQSTM1/p62 (autophagy marker)[1]. |
In vivo |
CLK1-IN-3 (0-40 mg/kg, intraperitoneal injection, single dose) significantly inhibits acute liver injury induced by acetaminophen (APAP) in the ALI model, and there is no apparent hepatocyte death observed[1]. CLK1-IN-3 (10 mg/kg; intravenous injection, oral administration, intraperitoneal injection, single dose) exhibits acceptable pharmacokinetic characteristics, with a relatively long half-life (T1/2) of 5.29 hours and an oral bioavailability of 19.5%[1]. |
Molecular Weight | 430.48 |
Formula | C24H23FN6O |
CAS No. | 2922550-28-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CLK1-IN-3 2922550-28-3 Autophagy Cell Cycle/Checkpoint Tyrosine Kinase/Adaptors DYRK CDK Benzamide,N[3(5fluoro3pyridinyl)1Hpyrrolo[2,3b]pyridin5yl]4(4methyl1piperazinyl) inhibitor inhibit